GABRP and central nervous system cancer: Kaplan–Meier analysis showed that although the high GABRP expression group showed a trend of increased risk of death (HR = 1.21, p = 0.114), it did not reach statistical significance, which may be limited by the current cohort sample size and molecular heterogeneity of glioma.